Submission Details
| 510(k) Number | K241304 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2024 |
| Decision Date | June 06, 2024 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K241304 is an FDA 510(k) clearance for the WaveSense Jazz Blood Glucose Monitoring System, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Agamatrix (Salem, US). The FDA issued a Cleared decision on June 6, 2024, 28 days after receiving the submission on May 9, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K241304 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 09, 2024 |
| Decision Date | June 06, 2024 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |